About Us

RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania.


Our Work

Our product pipeline includes a Phase-2 ready small molecule drug for the treatment of all forms of genetically-confirmed mitochondrial disease.

In addition to this product candidate, we have a proprietary drug discovery platform that targets transfer RNA with novel precision medicines for the treatment of mitochondrial and other diseases.


Leadership Team

Click picture for bio


Board of Directors

Click picture for bio


Scientific Advisors

Click picture for bio